Apple Barred From Selling Watches With Blood-Oxygen Sensors in U.S., CNBC Reports
--A federal appeals court has banned Apple from selling smartwatches with blood-oxygen sensors in the U.S., CNBC reports.
--The tech giant is in an intellectual property dispute with medical-technology company Masimo over the oxygen sensor feature on its Apple Watch models.
--The U.S. International Trade Commission ruled in October that the oxygen-sensor tool violated Masimo's patents.
--Apple removed some Apple Watch models from U.S. stores for several days in December after an import ban stemming from the ruling went into effect.
Full story: https://www.cnbc.com/2024/01/17/apple-again-banned-from-selling-watches-in-us-with-blood-oxygen-sensor.html
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
January 17, 2024 15:25 ET (20:25 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing